<DOC>
	<DOC>NCT02029040</DOC>
	<brief_summary>This is a randomized, double-blind, controlled trial in the Pediatric Emergency Department. The primary objective is to determine whether nebulized 3% hypertonic saline is more effective than nebulized 0.9% saline in the treatment of bronchiolitis in the emergency department.</brief_summary>
	<brief_title>Nebulized 3% Hypertonic Saline in the Treatment of Acute Bronchiolitis</brief_title>
	<detailed_description />
	<mesh_term>Bronchiolitis</mesh_term>
	<criteria>Children 212 months of age presenting to Emergency Department Patients with a diagnosis of bronchiolitis defined as the first episode of wheezing and/or crackles in a child younger than 12 months who has physical findings of a viral respiratory infection and has no other explanation for the wheezing and/or crackles Patients with an RDAI score â‰¥ 6 as measured by a trained respiratory therapist Previous history of wheezing Known heart or lung disease Premature birth defined as birth before 37 weeks gestation Immunosuppression or immunodeficiency Treatment with corticosteroids in the previous 48 hours Critically ill children progressive respiratory failure requiring higher level of care, vital signs instability/need for emergency interventions to prevent clinical deterioration Oxygen saturation &lt;85% on room air at the time of recruitment</criteria>
	<gender>All</gender>
	<minimum_age>2 Months</minimum_age>
	<maximum_age>12 Months</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Bronchiolitis</keyword>
	<keyword>Hypertonic saline</keyword>
	<keyword>Emergency Department</keyword>
</DOC>